Ginkgo Bioworks Reports First Quarter 2025 Financial Results
Provided By PR Newswire
Last update: May 6, 2025
Ginkgo provides an update on its restructuring, including progress towards its expanded $250 million cost savings target
Ginkgo and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems
Read more at prnewswire.com
